Regeneron Pharmaceuticals (REGN)
(Real Time Quote from BATS)
$1,058.76 USD
+3.19 (0.30%)
Updated Jul 24, 2024 03:00 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/1/24 |
---|---|
Current Quarter | 10.49 |
EPS Last Quarter | 9.55 |
Last EPS Surprise | -6.37% |
ABR | 1.54 |
Earnings ESP
|
0.42% |
---|---|
Current Year | 43.57 |
Next Year | 46.45 |
EPS (TTM) | 43.24 |
P/E (F1) | 24.23 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.38B | 3.61B | 13.95B | 14.97B |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 3.51B | 3.78B | 14.42B | 15.63B |
Low Estimate | 3.14B | 3.40B | 13.33B | 13.96B |
Year ago Sales | 3.16B | 3.36B | 13.12B | 13.95B |
Year over Year Growth Est. | 7.08% | 7.41% | 6.31% | 7.32% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.49 | 12.03 | 43.57 | 46.45 |
# of Estimates | 10 | 9 | 12 | 11 |
Most Recent Consensus | 8.90 | 9.69 | 38.82 | 41.00 |
High Estimate | 12.66 | 14.31 | 51.53 | 55.84 |
Low Estimate | 8.90 | 9.69 | 38.82 | 41.00 |
Year ago EPS | 10.24 | 11.59 | 43.79 | 43.57 |
Year over Year Growth Est. | 2.44% | 3.80% | -0.50% | 6.61% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 2 | 2 | 2 | 1 |
Down Last 30 Days | 4 | 3 | 4 | 2 |
Down Last 60 Days | 5 | 4 | 5 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 10.49 | 12.03 | 43.57 | 46.45 |
7 Days Ago | 10.54 | 12.11 | 43.71 | 46.49 |
30 Days Ago | 10.57 | 12.14 | 43.77 | 46.55 |
60 Days Ago | 10.61 | 12.22 | 43.85 | 46.74 |
90 Days Ago | 11.07 | 12.42 | 45.35 | 47.36 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 10.53 | 11.91 | 44.65 | 50.49 |
Zacks Consensus Estimate | 10.49 | 12.03 | 43.57 | 46.45 |
Earnings ESP | 0.42% | -1.04% | 2.48% | 8.70% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 9.55 | 11.86 | 11.59 | 10.24 | NA |
Estimate | 10.20 | 10.43 | 10.80 | 9.92 | NA |
Difference | -0.65 | 1.43 | 0.79 | 0.32 | 0.47 |
Surprise | -6.37% | 13.71% | 7.31% | 3.23% | 4.47% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more